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Purpose: To investigate the contactin-associated protein-like 2 (CNTNAP2) gene for single-nucleotide polymorphisms
(SNPs) in Japanese patients with the exfoliation syndrome (XFS).
Methods: One hundred and eight unrelated Japanese patients with the XFS, and 199 normal controls were studied.
Genomic DNA was extracted from the leukocytes of the peripheral blood, and 8 SNPs, rs826802, rs1404699, rs7803992,
rs700308, rs4725736, rs2107856, rs2141388, and rs6970064, were amplified by polymerase chain reaction (PCR), directly
sequenced, and genotyped.
Results: The allele frequencies of rs1404699 (p=8.57XE-3, odds ratio (OR)=1.59, 95% confidential intervals (CI); 1,12–
2.24) and rs7803992 (p=5.43XE-4, OR=1.86, 95% CI; 1.31–2.65) were statistically significantly different between XFS
and controls. In addition, there were significant differences in these genotype frequencies (p=0.0197 and 1.75XE-3). The
allele and the genotype frequencies of rs2107856 and rs2141388, which were statistically significant SNPs in an earlier
study, were not significantly different.
Conclusions: The variants, rs1404699 and rs7803992, of CNTNAP2 should be associated with XFS in the Japanese
population.
The exfoliation syndrome (XFS; OMIM 177650) is a
generalized  disorder  of  the  extracellular  matrix  and  is
characterized clinically by the pathological accumulation of
abnormal fibrillar material in the anterior segment of the eye
[1-3].  This  predisposes  the  eye  to  glaucomatous  optic
neuropathy.  The  XFS  has  also  been  associated  with  lens
zonule  weakness,  severe  chronic  secondary  open-angle
glaucoma, cataract formation, and also a spectrum of other
serious spontaneous and surgical intraocular complications.
The  prevalence  of  XFS  varies  markedly  between
populations being highest in Scandinavian countries, while
the  Anglo-Celtic  Caucasians  have  a  markedly  lower
prevalence [4-7]. The incidence increases with age and is
highest in the age group between 70 and 80 years [5]. The
prevalence of XFS in Japan was reported to be 1.1% in one
study [8] and 4.8% in another study [9].
Thorleifsson  et  al.  [10]  found  a  strong  association
between single-nucleotide polymorphisms (SNPs) in the lysyl
oxidase–like 1 (LOXL1) gene and XFS in the Swedish and
Icelandic populations using a genome-wide association study
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(GWAS). This association was replicated in the United States
of America [11-13] and also in other populations [14-23].
LOXL1  is  a  member  of  the  lysyl  oxidase  family  of
proteins that catalyzes the oxidative deamination of lysine
residues of tropoelastin [24]. The homeostasis of elastic fibers
requires the lysyl oxidase-like 1 protein [25], and LOXL1
plays an important role in elastogenesis. Thus, it is quite
possible that defects in LOXL1 can cause features of XFS that
result from an aberrant production of elastin and accumulation
of fibrillar materials in the anterior segment of the eye.
A GWAS was recently performed using a DNA-pooling
approach, and a single genotype at the contactin-associated
protein-like 2 (CNTNAP2) locus had significant associations
between  XFS  and  exfoliation  glaucoma  and  two  SNPs
(rs2107856 and rs2141388). These findings were confirmed
in an independent German cohort but not in an Italian cohort
[26]. CNTNAP2 is a large gene spanning 2.3 mb of DNA on
chromosome 7 and has 24 exons, and codes for the contactin-
associated  protein-like  2  (CNTNAP2,  also  called  Caspr2).
CNTNAP2 is member of the neurexin superfamily [27,28]
and is possibly involved in stabilizing the location of the
potassium channels in the juxtaparanodal region of the neuron
[27]. It has been suggested to be a candidate gene for various
neuropsychiatric disorders, e.g., the cortical dysplasia-focal
epilepsy  syndrome  [29]  and  Pitt-Hopkins-like  mental
retardation [30]. However, its exact function and regulation
are not known.
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1395The purpose of this study was to investigate 8 SNPs
variations in CNTNAP2 in Japanese patients with the XFS.
METHODS
One hundred and eight unrelated Japanese patients with XFS
(mean age 73.61±6.75 years; 57 men, 51 women) and 199
controls (mean age 69.7±11.3 years; 101 men, 98 women)
were studied. The controls were matched by age and gender.
The  XFS  group  included  85  exfoliation  glaucoma  (XFG)
patients. They were examined at the ophthalmic clinic of the
Tohoku University Hospital, Sendai, Japan, and the Ehime
University  Hospital,  Ehime,  Japan.  The  purpose  and
procedures were explained to all patients, and an informed
consent  was  obtained.  This  study  was  approved  by  the
Institutional Review Boards of the Tohoku University and
Ehime University, and the procedures used conformed to the
tenets of the Declaration of Helsinki.
Routine ophthalmic examinations were performed on all
patients. The criteria used to classify a patient as having XFS
was an open anterior chamber angle with accumulation of
abnormal fibrillar material in the anterior segment of the eye.
In addition, three other criteria for XFG had to be met: 1)
applanation intraocular pressure (IOP) >22 mmHg in each
eye; 2) glaucomatous cupping in each eye including a cup-to-
disc ratio >0.7; and 3) visual field defects determined by
Goldmann  perimetry  and/or  Humphrey  field  analyzer
consistent with the glaucomatous cupping in at least one eye.
The control subjects had the following characteristics: 1) IOP
less than 22 mmHg; 2) normal optic discs; and 3) no family
history of glaucoma.
Genomic  DNA  was  extracted  from  the  leukocytes  of
peripheral blood and purified with the Qiagen QIAamp Blood
Kit (Qiagen, Valencia, CA). Genomic DNA was extracted
from the leukocytes of the peripheral blood, and the 6 SNPs,
rs1404699, rs700308, rs4725736, rs2107856, rs2141388, and
rs6970064, were chosen from the earlier studies. Two newly
identified  SNPs,  rs826802  and  rs7803992,  were  designed
around intron 9 of the gene. The CNTNAP2 gene structure
with the location of the 8 SNPs is shown in Figure 1. They
were amplified by polymerase chain reaction (PCR), directly
sequenced,  and  genotyped.  The  amplifications  were
performed  at  60  °C  annealing  temperature.  The  PCR
fragments were purified with ExoSAP-IT (USB, Cleveland,
OH),  sequenced  by  the  BigDyeTM  Terminator  v3.1  Cycle
Sequencing  Kit  (Perkin-Elmer,  Foster  City,  CA)  by  an
automated  DNA  sequencer  (ABI  PRISMTM  3100  Genetic
Analyzer, Perkin-Elmer). The allele frequencies, genotypes,
and haplotypes of the CNTNAP2 SNPs were determined.
Statistical  analysis:  The  significance  of  associations
between  the  phenotype  and  SNPs  were  determined  by
contingency table analysis using chi-square or Fisher's exact
test. The odds ratios, approximating to relative risks, were
calculated  as  a  measure  of  the  association  between  the
CNTNAP2 allele frequency and the phenotype. For each odds
ratio,  the  95%  confidence  intervals  were  calculated.  The
inferred haplotypes, quantified between all pairs of biallelic
loci, were estimated using the SNPAlyze program version 7.0
(Dynacom, Yokohama, Japan). Additionally, a permutation
test was performed to test the deviations of allelic frequencies
of  the  SNPs  and  haplotypes.  The  Hardy–Weinberg
equilibrium was analyzed using gene frequencies obtained by
simple  gene  counting  and  the  chi-square  test  with  Yates'
correction for comparing observed and expected values.
RESULTS
The  allele  frequencies  and  genotypes  of  the  8  CNTNAP2
SNPs,  rs826802,  rs1404699,  rs7803992,  rs700308,
rs4725736,  rs2107856,  rs2141388,  and  rs6970064,  were
determined in the XFS patients.
Figure 1. CNTNAP2 gene structure. The 8 SNPs studied were; 1. rs826802, 2. rs144699, 3. rs7803992, 4. rs700308  , 5. rs4725736, 6.
rs2107856, 7. rs2141388, and 8. rs6970064. SP, signal peptide; DISC, discoidin-like domain; LamG, laminin-G domain; EGF, epidermal
growth factor like domain; FIB, fibrinogen-like domain;TM, transmembrane region; PDZBD, PDZ-domain binding site.
Molecular Vision 2012; 18:1395-1401 <http://www.molvis.org/molvis/v18/a145> © 2012 Molecular Vision
1396Distribution of CNTNAP2 variants in XFS patients and
control  subjects:  The  allele  frequencies  of  rs1404699
(p=8.57XE-3,  odd  ratio  (OR)=1.59,  95%  confidential
intervals  (CI);  1,12–2.24)  and  rs7803992  (p=5.43XE-4,
OR=1.86, 95% CI; 1.31–2.65) were statistically significant
between the XFS group and the control group (Table 1). There
were  also  significant  differences  in  these  genotype
frequencies  (p=0.0197  and  1.75XE-3;  Table  2).  Only  the
rs7803992 was significantly different between the XFG group
and the control group (p=0.016; Table 1). Compared with the
allele frequencies of rs2107856 and rs2141388 statistically
significant SNPs in a previous study [26], our results showed
no significantly difference between the XFS group and the
control group (Table 1). Also, the genotype frequencies of
those in CNTNAP2 were not significantly higher in the two
groups than in the control group (Table 2).
The genotype frequencies of rs700308 and rs6970064
were statistically significant (p=0.0402 and 0.0315), but the
allele frequencies were not significantly different (p=0.553
and 0.0524) between the XFS group and the control group.
All  SNPs  adhered  to  the  Hardy–Weinberg  expectations
(p>0.05).
Haplotype  analyses  at  CNTNAP2  LD  block  in  the
Japanese population: The inferred haplotypes between all
pairs  of  biallelic  loci  on  rs1404699  and  rs7803992  were
estimated (Table 3). The haplotype-based associations were
tested  with  a  1,000  iterated  permutation  test.  Four  major
haplotypes; C-A, T-G, T-A, C-G (each frequency >5%) were
found in the XFS subjects and normal controls. T-G was over-
represented  in  the  XFS  subjects  with  a  highly  significant
difference in frequency compared to the control group (0.327
versus 0.202; p=0.003). In addition, the C-A haplotype was
significantly  less  represented  in  the  XFS  subjects  (0.522
versus 0.637; p=0.003).
Two  locus  analyses:  A  strong  correlation  between
variants in LOXL1 and XFS has been reported [10], LOXL1
common risk haplotype is T-G (the major alleles T of the
coding SNPs rs1048661 and major alleles G of the coding
SNPs rs3825942) in Japan, instead of G-G in Europeans. We
investigated how the variants in LOXL1 gene were related to
CNTNAP2.  We  sorted  our  subjects  for  carriers  and  non-
carriers of the risk haplotype T-G (Table 4). The numbers in
the subgroup of non-T-G carriers was quite small, and there
was no association of CNTNAP2 SNPs with the LOXL1 non-
risk  haplotype  (Table  4;  p=0.53  and  0.69,  respectively).
Besides the subgroups risk of T-G carriers, there was no
significant  association  (Table  4;  p=0.072  and  0.084,
respectively).
DISCUSSION
Association between CNTNAP2 and XFS: We compared the
findings of Krumbiegel and colleagues [26] to that obtained
TABLE 1. CNTNAP2 ALLELE FREQUENCIES IN PATIENTS WITH EXFOLIATION SYNDROME AND IN CONTROLS IN JAPANESE.
MAF in this study MAF in previous study*
dbSNP Allele XFS (n=108)
XFG (n=85)
Control
(n=199)                                            (n=770)
p-value                  XFS                   Control
(n=444)
p-value
rs826802 T 0.435 0.372 0.0884 N/A N/A N/A
    0.429   0.0198      
rs1404699 T 0.412 0.307 8.57XE-3 0.445 0.397 0.0225
    0.388   0.0581      
rs7803992 G 0.394 0.259 5.43XE-4 N/A N/A N/A
    0.359   0.016      
rs700308 A 0.407 0.432 0.553 0.138 0.103 0.0117
    0.412   0.653      
rs4725736 A1 0.472 0.402 0.093 0.585 0.637 0.0121
    0.441   0.385      
rs2107856 G2 0.450 0.432 0.687 0.709 0.776 0.0003
    0.441   0.843      
rs2141388 C3 0.444 0.437 0.863 0.709 0.777 0.0002
    0.441   0.930      
rs6970064 A4 0.181 0.123 0.0524 0.418 0.463 0.0306
    0.182   0.0631      
         *reported by Krumbiegel et al. [26]. MAF; minor allele frequency, XFS; Exfoliation Syndrome, XFG; Exfoliation Glaucoma.
         The significance of the association was determined by a contingency table analysis using the χ2 test. Upper columns show XFS
         data, and lower columns show XFG data. 1. There was a difference between the Caucasian and Japanese. Minor allele in previous
         study was C. 2. Minor Allele in previous study was T. 3. Minor Allele in previous study was T. 4. Minor Allele in previous
         study was G.
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1397from  our  Japanese  cohorts.  We  found  that  two  SNPs  in
CNTNAP2 were strongly associated with XFS. In an earlier
study [26], the frequencies of rs2107856 and rs2141388 SNPs
in  CNTNAP2  were  confirmed  in  an  independent  German
cohort  but  not  in  the  Italian  cohort.  Although  neither  the
rs2107856 or rs2141388 SNPs was significant in our study,
rs1404699 and nearby rs7803992 were statistically significant
between the XFS group and the control group. Thus, it is
possible that CNTNAP2 could be associated with XFS. Like
other susceptible variants of a complex disease, the OR in the
earlier study was modest at about 1.4. In our study, the highest
OR was 1.86 for rs7803992. This difference can be explained
by racial differences and heterogeneities. Because the number
of XFG patients was small, it seemed that the statistical power
was weak.
No association between CNTNAP2 and LOXL1 in Japanese:
Because a strong association of variants in LOXL1 in XFS has
been reported [10], we compared the allele frequencies at
CNTNAP2  locus  based  on  the  presence  of  the  identified
Japanese LOXL1 common risk haplotype T-G. We found no
significant  association  to  allele  T  of  the  rs1404699  and
rs7803992 SNPs of CNTNAP2 in carriers of LOXL1 the risk
T-G haplotype (Table 4), and also in non-risk haplotypes.
These findings suggest that there is no association between
TABLE 2. FREQUENCY OF GENOTYPES CNTNAP2 GENE IN PATIENTS WITH EXFOLIATION SYNDROME AND IN CONTROLS IN JAPANESE.
dbSNP Allele XFG (n=108) p value* XFG (n=85) p value* Control (n=199)
rs826802 G/G 36 (33.3) 0.224 27 (31.8) 0.425 77 (38.7)
  G/T 50 (46.3)   43 (50.6)   96 (48.2)
  T/T 22 (20.4)   15 (17.6)   26 (13.1)
rs1404699 C/C 38 (35.2) 0.0197 32 (37.6) 0.121 93 (46.7)
  C/T 51 (47.2)   40 (47.1)   90 (45.2)
  T/T 19 (17.6)   13 (15.3)   16 (8.1)
rs7803992 A/A 38 (35.2) 1.75XE-3 31 (36.5) 6.22XE-3 112 (56.3)
  A/G 55 (50.9)   47 (55.3)   71 (35.7)
  G/G 15 (13.9)   7 (8.2)   16 (8.0)
rs700308 G/G 45 (41.7) 0.0402 33 (38.8) 0.282 63 (31.7)
  G/A 38 (35.2)   34 (40.0)   100 (50.3)
  A/A 25 (23.1)   18 (21.2)   36 (18.1)
rs4725736 C/C 34 (31.5) 0.0659 27 (31.8) 0.385 69 (34.7)
  C/A 46 (42.6)   41 (48.2)   100 (50.3)
  A/A 28 (25.9)   17 (20.0)   30 (15.1)
rs2107856 T/T 39 (36.1) 0.091 29 (34.1) 0.541 63 (31.7)
  T/G 41 (38.0)   37 (43.5)   100 (50.3)
  G/G 28 (25.9)   19 (22.4)   36 (18.1)
rs2141388 T/T 39 (36.1) 0.100 29 (34.1) 0.470 61 (30.7)
  T/C 42 (38.9)   37 (43.5)   106 (53.3)
  C/C 27 (25.0)   19 (22.4)   32 (16.1)
rs6970064 G/G 74 (68.5) 0.0315 58 (68.2) 0.0345 151 (75.9)
  G/A 29 (26.9)   23 (27.1)   47 (23.6)
  A/A 5 (4.6)   4 (4.7)   1 (0.5)
        XFS; Exfoliation Syndrome, XFG; Exfoliation Glaucoma. Data presented are number of patients, unless otherwise indicated.
        The significance of the association was determined by a contingency table analysis using the χ2 test.
TABLE 3. HAPLOTYPE ANALYSIS WITH RS1404699 AND RS7803992 IN PATIENTS WITH EXFOLIATION SYNDROME AND IN CONTROLS IN
JAPANESE.
Haplotype Overall XFS Control p-value
C-A 0.5966 0.5217 0.637 0.003
T-G 0.2464 0.3273 0.2024 0.003
T-A 0.0972 0.0847 0.1041 0.489
C-G 0.0597 0.0662 0.0564 0.708
        XFS; Exfoliation Syndrome. The significance of the association was determined by a contingency table analysis using the χ2
        test.
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1398CNTNAP2 and LOXL1 in the Japanese. This would then mean
that  a  LOXL1-independent  mechanism  is  involved  in
CNTNAP2 function.
In a molecular genetic study, the most promising loci at
18q12.1–21.33 and 2q, 17p, and 19q have been proposed to
be the susceptible loci in a Finnish population in an autosomal
dominant mode of inheritance [31]. In a microarray study, 23
genes  with  different  expression  patterns  in  the  anterior
segment tissues of eyes with XFS have recently been reported
[32].  This  strongly  suggests  that  an  unidentified  gene  or
environmental  factors  independent  of  the  LOXL1  gene
strongly influence the phenotypic expression of the XFS.
CNTNAP2 function and molecular genetics: CNTNAP2 is a
single-pass  transmembrane  protein  with  multiple  protein-
interaction motifs typical of the neurexins, e.g., epidermal
growth factor repeats, laminin globular domains, and F5/8-
type C domain, and a putative PDZ-binding site. Poliak et al.
[33] reported that CNTNAP2 is necessary to maintain the
potassium channels at the juxtaparanodal region in myelinated
axons. The SNPs we selected were located in introns 9, 10,
and 11 (Figure 1), while several SNPs related to autism were
located  in  intron  2  [34]  and  intron  13  [35].  The  cortical
dysplasia-focal  epilepsy  syndrome  is  caused  by  a  single
nucleotide deletion in Exon 22. Therefore, it seems that our
SNPs  have  nearly  no  correlation  with  neuropsychiatric
disorders. The rs1404699 and rs7803992 SNPs are located in
intron 9 of the CNTNAP2 gene. Exon 9, nearby to intron 9,
codes  for  the  laminin  globular  domain,  which  contains
proteins that play a wide variety of roles in cell adhesion,
signaling, migration, assembly, and differentiation of cells.
We suggest that alterations in membrane stabilization may
contribute  to  the  abnormal  exfoliation  matrix  processes,
which are associated with cell-surface irregularities, basement
membrane destruction and degenerative alterations.
Conclusions: Identification of XFS-associated SNPs that will
allow early detection of an increase in the IOP, or even before
an elevation of IOP, would be desirable. Our findings showed
that  variants  of  CNTNAP2  rs1404699  and  rs7803992  are
significantly associated with XFS in the Japanese population.
More  studies  of  the  functions  and  genotype-phenotype
correlation  of  CNTNAP2  are  required  to  determine  the
pathophysiology  of  XFS.  In  addition,  further  studies
searching for secondary genetic and environmental factors
that contribute to XFS is required to gain better understanding
of the complex etiology of XFS.
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